<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In severe <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>, <z:chebi fb="11" ids="18295">histamine</z:chebi> 3 (H₃) receptor activation affords cardioprotection by preventing excessive <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> release and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>; pivotal to this action is the inhibition of neuronal Na⁺/H⁺ exchanger (NHE) </plain></SENT>
<SENT sid="1" pm="."><plain>Conversely, <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi>, formed locally by mast cell-derived renin, stimulates NHE via <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 (AT₁) receptors, facilitating <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> release and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, ischemic dysfunction may depend on a balance between the NHE-modulating effects of H₃ receptors and AT₁ receptors </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this investigation was therefore to elucidate the H₃/AT₁ receptor interaction in <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>We found that H₃ receptor blockade with clobenpropit increased <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> overflow and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in Langendorff-perfused guinea pig hearts subjected to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>This coincided with increased neuronal AT₁ receptor expression </plain></SENT>
<SENT sid="6" pm="."><plain>NHE inhibition with cariporide prevented both increases in <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> release and AT₁ receptor expression </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> release and AT₁ receptor expression were increased by the nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthase inhibitor N(G)-<z:chebi fb="36" ids="29309">methyl</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> and the protein kinase C activator <z:chebi fb="0" ids="8116">phorbol</z:chebi> <z:chebi fb="0" ids="30807">myristate</z:chebi> <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>H₃ receptor activation in differentiated sympathetic neuron-like PC12 cells permanently transfected with H₃ receptor cDNA caused a decrease in protein kinase C activity and AT₁ receptor protein abundance </plain></SENT>
<SENT sid="9" pm="."><plain>Collectively, our findings suggest that neuronal H₃ receptor activation inhibits NHE by diminishing protein kinase C activity </plain></SENT>
<SENT sid="10" pm="."><plain>Reduced NHE activity sequentially causes intracellular acidification, increased NO synthesis, and diminished AT₁ receptor expression </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, H₃ receptor-mediated NHE inhibition in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion not only opposes the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi>-induced stimulation of NHE in cardiac sympathetic neurons, but also down-regulates AT₁ receptor expression </plain></SENT>
<SENT sid="12" pm="."><plain>Cardioprotection ultimately results from the combined attenuation of <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> and <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> effects and alleviation of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
</text></document>